Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Giandomenico V, Modlin IM, Pontén F, Nilsson M, Landegren U, Bergqvist J, Khan MS, Millar RP, Långström B, Borlak J, Eriksson B, Nielsen B, Baltzer L, Waterton JC, Ahlström H, Öberg K.

Neuroendocrinology. 2013;98(1):16-30. doi: 10.1159/000348832.

2.

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.

Turaga KK, Kvols LK.

CA Cancer J Clin. 2011 Mar-Apr;61(2):113-32. doi: 10.3322/caac.20097.

3.

Current knowledge on diagnosis and staging of neuroendocrine tumors.

Oberg K, Castellano D.

Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:3-7. doi: 10.1007/s10555-011-9292-1. Review.

PMID:
21311954
4.

The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.

Lawrence B, Gustafsson BI, Kidd M, Pavel M, Svejda B, Modlin IM.

Endocrinol Metab Clin North Am. 2011 Mar;40(1):111-34, viii. doi: 10.1016/j.ecl.2010.12.001. Review.

PMID:
21349414
5.

Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Minter RM, Simeone DM.

J Gastrointest Surg. 2012 Feb;16(2):435-46. doi: 10.1007/s11605-011-1693-5. Review.

PMID:
22009463
6.

Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.

Lindholm DP, Oberg K.

Horm Metab Res. 2011 Nov;43(12):832-7. doi: 10.1055/s-0031-1287794. Review.

PMID:
22009449
7.

Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.

Singh S, Law C.

Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):313-34. doi: 10.1586/egh.12.15. Review.

PMID:
22646254
8.

Biomarkers in pancreatic neuroendocrine tumors.

Theochari MS, Syrigos KN, Saif MW.

JOP. 2014 Mar 10;15(2):138-9. doi: 10.6092/1590-8577/2321.

9.

Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.

Cui T, Hurtig M, Elgue G, Li SC, Veronesi G, Essaghir A, Demoulin JB, Pelosi G, Alimohammadi M, Öberg K, Giandomenico V.

PLoS One. 2010 Dec 30;5(12):e16010. doi: 10.1371/journal.pone.0016010.

10.

Neuroendocrine tumors: recent progress in diagnosis and treatment.

Oberg K.

Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:E3-6. doi: 10.1530/ERC-10-0288. No abstract available.

11.

Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?

Crona J, Granberg D, Norlén O, Wärnberg F, Stålberg P, Hellman P, Björklund P.

World J Surg. 2013 Jul;37(7):1701-6. doi: 10.1007/s00268-013-2037-2.

PMID:
23592057
12.
13.

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.

Stevenson R, Libutti SK, Saif MW.

JOP. 2013 Mar 10;14(2):155-7. doi: 10.6092/1590-8577/1472. Review.

14.

Biochemical diagnosis of neuroendocrine GEP tumor.

Oberg K.

Yale J Biol Med. 1997 Sep-Dec;70(5-6):501-8. Review.

15.

Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.

Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E.

J Natl Cancer Inst. 2008 Sep 17;100(18):1282-9. doi: 10.1093/jnci/djn275.

16.

Future perspectives on neuroendocrine tumors.

Castellano D, Salazar R, Raymond E.

Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:35-40. doi: 10.1007/s10555-011-9294-z. Review.

PMID:
21327890
17.

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

Alexandraki KI, Kaltsas G.

Endocrine. 2012 Feb;41(1):40-52. doi: 10.1007/s12020-011-9562-2. Review.

PMID:
22124940
18.

Neuroendocrine tumor disease: an evolving landscape.

Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM.

Endocr Relat Cancer. 2012 Sep 14;19(5):R163-85. doi: 10.1530/ERC-12-0024. Review.

19.

Biomarkers in neuroendocrine tumors.

Duque M, Modlin IM, Gupta A, Saif MW.

JOP. 2013 Jul 10;14(4):372-6. doi: 10.6092/1590-8577/1692.

20.

Laboratory tests for neuroendocrine tumours.

Seregni E, Ferrari L, Stivanello M, Dogliotti L.

Q J Nucl Med. 2000 Mar;44(1):22-41. Review.

PMID:
10932599

Supplemental Content

Support Center